Traumatic brain injury

On 1 September 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 390. The active ingredient is 4-amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride for treatment of moderate and severe traumatic brain injury.